Please login to the form below

Not currently logged in
Email:
Password:

genomics

This page shows the latest genomics news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Merck KGaA signs deal with Artios Pharma potentially worth up to $860m

Cancer cells need nucleases – an enzyme involved in the maintenance of genomic integrity – to survive in response to DNA damage.

Latest news

  • Building a brighter future for rare disease patients Building a brighter future for rare disease patients

    Since 80 per cent of rare diseases have a genetic cause, new advances in genomics have also boosted the hopes of patients living with rare diseases by enabling more targeted approaches

  • UCB boosts gene therapy offering with a pair of new deals UCB boosts gene therapy offering with a pair of new deals

    The Handl and Lacerta deals build on UCB’s previous acquisition of Element Genomics in 2018. ... UCB paid $30m to access Element’s platform of technologies aimed at improving the understanding of genome structure and function – including CRISPR

  • GSK and Vir Biotech expand phase 3 COVID-19 antibody study GSK and Vir Biotech expand phase 3 COVID-19 antibody study

    The collaboration combines Vir Biotech’s monoclonal antibody platform technology with GSK’s expertise in functional genomics and capabilities in CRISPR screening to identify anti-coronavirus compounds.

  • Stop that! Stop that!

    My ‘x plus y causes z’ mental model, shaped by a physical sciences education, was that some factors, like the genomic revolution and globalisation, would lead to a new business model

  • We've got this! We've got this!

    More recently, we have witnessed the transformational impact of genomics, new materials in medical devices, robotics and information technology in medical technologies and immunotherapies in oncology.

More from news
Approximately 23 fully matching, plus 166 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 8 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 19 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 17 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics